About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Immunotherapy Agent Can Reduce Viral Levels in SIV-Infected Monkeys

by Shirley Johanna on February 26, 2016 at 6:50 PM
Font : A-A+

Immunotherapy Agent Can Reduce Viral Levels in SIV-Infected Monkeys

Immunotherapy can push SIV (simian immunodeficiency virus) out of its hiding place in infected monkeys that have the virus controlled with drugs, say scientists at Yerkes National Primate Research Center, Emory University report.

The results were presented on February 24 at the Conference on Retroviruses and Opportunistic Infections in Boston by graduate student Geetha Mylvaganam.

Advertisement


Rama Rao Amara, PhD, professor of microbiology and immunology at Yerkes and the Emory Vaccine Center, led the project. Collaborators include Rafi Ahmed, PhD, director of Emory Vaccine Center and a Georgia Research Alliance Eminent Scholar, and Gordon Freeman, PhD, of Dana-Farber Cancer Institute. Mylvaganam is part of the Immunology and Molecular Pathogenesis graduate program at Emory.

Antiretroviral drugs can usually control HIV in chronically infected people, but they can't completely eliminate it. That's because some immune cells harboring the virus remain dormant. A strategy has emerged called "shock and kill" or "kick and kill", aimed at activating those cells, so that the virus can be flushed out.
Advertisement

The Yerkes team tested the effects of blocking PD-1, a molecule that inhibits the immune response during chronic infections, in combination with antiretroviral therapy. Antibodies that block PD-1 have also been tested, with some success, as cancer immunotherapy agents. The team developed a "primatized" anti-PD-1 antibody, to reduce monkeys' immune responses to the antibody itself and enable repeated infusions.

With some SIV-infected monkeys, the researchers treated them with anti-PD-1 antibody for 14 days, starting from 10 days before antiretroviral therapy began. In this situation, the anti-PD-1-treated animals showed more rapid viral suppression (average 42 days in the PD-1 group versus 140 days in controls) and more active antiviral T cells.

In addition, other SIV-infected monkeys were treated with anti-PD-1 antibody (three infusions, with a month between each) after antiretroviral therapy had brought viral levels to a very low level. This resulted in transient reappearances of SIV in their blood, not seen in control animals.

The researchers conclude, "These results reveal for the first time the potential of PD-1 blockade, both on restoring anti-viral CD8 T cell function, and possibly destabilizing the viral reservoir under ART. They highlight the potential of PD-1 blockade to work synergistically with other therapeutic agents such as vaccines and latency reversing agents to effectively diminish HIV reservoir under ART as a means to establish a functional cure."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Know More About Mitochondria
Top 10 Foods for Decreasing DHT Production and Preventing Hair Fall
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Immunisation Dealing with Pollen Allergy Immune Checkpoint Inhibitors for Cancer Treatment 

Most Popular on Medindia

Nutam (400mg) (Piracetam) Blood Pressure Calculator Loram (2 mg) (Lorazepam) Vent Forte (Theophylline) Find a Hospital Drug - Food Interactions The Essence of Yoga A-Z Drug Brands in India Indian Medical Journals Blood Donation - Recipients
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Immunotherapy Agent Can Reduce Viral Levels in SIV-Infected Monkeys Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests